| 5TQ4: reference: Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin., Jones P, Storer RI, Sabnis YA, Wakenhut FM, Whitlock GA, England KS, Mukaiyama T, Dehnhardt CM, Coe JW, Kortum SW, Chrencik JE, Brown DG, Jones RM, Murphy JR, Yeoh T, Morgan P, Kilty I, J Med Chem. 2017 Jan 4. doi: 10.1021/acs.jmedchem.6b01634. PMID: 27983835 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).